Yi Gou

1.9k total citations
63 papers, 1.6k citations indexed

About

Yi Gou is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Yi Gou has authored 63 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 22 papers in Organic Chemistry and 18 papers in Molecular Biology. Recurrent topics in Yi Gou's work include Metal complexes synthesis and properties (39 papers), Protein Interaction Studies and Fluorescence Analysis (13 papers) and Synthesis and Characterization of Heterocyclic Compounds (12 papers). Yi Gou is often cited by papers focused on Metal complexes synthesis and properties (39 papers), Protein Interaction Studies and Fluorescence Analysis (13 papers) and Synthesis and Characterization of Heterocyclic Compounds (12 papers). Yi Gou collaborates with scholars based in China, United States and Czechia. Yi Gou's co-authors include Feng Yang, Jinxu Qi, Zuping Zhou, Hong Liang, Hong Liang, Jungang Deng, Jinlong Li, Ping Yu, Xiaoyang Wu and Guojin Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Coordination Chemistry Reviews and Journal of Medicinal Chemistry.

In The Last Decade

Yi Gou

58 papers receiving 1.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yi Gou 1.1k 703 425 356 262 63 1.6k
Celine J. Marmion 1.1k 1.1× 960 1.4× 546 1.3× 331 0.9× 297 1.1× 42 1.8k
Muhammad Nafees 972 0.9× 733 1.0× 504 1.2× 218 0.6× 451 1.7× 36 1.9k
Ahmed M. Mansour 1.1k 1.0× 1.2k 1.7× 671 1.6× 288 0.8× 331 1.3× 130 2.4k
Adnan S. Abu‐Surrah 666 0.6× 1.2k 1.7× 174 0.4× 388 1.1× 249 1.0× 69 1.7k
Claire S. Allardyce 1.7k 1.6× 1.5k 2.1× 583 1.4× 356 1.0× 371 1.4× 16 2.5k
Ke-Bin Huang 727 0.7× 667 0.9× 364 0.9× 225 0.6× 211 0.8× 47 1.5k
Ignácio E. León 917 0.9× 617 0.9× 388 0.9× 665 1.9× 191 0.7× 79 1.8k
Margot N. Wenzel 438 0.4× 630 0.9× 205 0.5× 213 0.6× 265 1.0× 22 1.4k
Jinxu Qi 627 0.6× 437 0.6× 598 1.4× 205 0.6× 328 1.3× 45 1.4k

Countries citing papers authored by Yi Gou

Since Specialization
Citations

This map shows the geographic impact of Yi Gou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Gou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Gou more than expected).

Fields of papers citing papers by Yi Gou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Gou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Gou. The network helps show where Yi Gou may publish in the future.

Co-authorship network of co-authors of Yi Gou

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Gou. A scholar is included among the top collaborators of Yi Gou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Gou. Yi Gou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Kai, Xiaowen He, Yi Gou, et al.. (2025). Scutellarin alleviates ferroptosis in cigarette smoke-induced chronic obstructive pulmonary disease via activation of the PI3K/AKT/Nrf2 signaling pathway. Journal of Ethnopharmacology. 357. 120870–120870. 1 indexed citations
2.
Chen, Lei, Xiaoyun Lu, Zu‐Yu Mo, et al.. (2025). Design, synthesis and evaluation of diarylidenyl piperidone-ligated platinum (IV) complexes as chemoimmunotherapeutic agents. European Journal of Medicinal Chemistry. 287. 117338–117338. 1 indexed citations
3.
Zhou, Jie, et al.. (2025). Roles of gastric cancer-derived exosomes in the occurrence of metastatic hepatocellular carcinoma. Progress in Biophysics and Molecular Biology. 196. 1–7.
4.
5.
6.
Pan, Wei‐Ping, et al.. (2024). Hydrazone copper(II) complexes suppressed lung adenocarcinoma by activating multiple anticancer pathway. Bioorganic Chemistry. 154. 107994–107994. 2 indexed citations
7.
Lan, Jianfeng, et al.. (2024). Assessment of Mononuclear/Dinuclear copper acylhydrazone complexes for lung cancer treatment. Bioorganic Chemistry. 144. 107122–107122. 13 indexed citations
8.
Dai, Wenjie, Ling Liu, Shengming Li, et al.. (2022). Identification of biomarkers and the mechanisms of multiple trauma complicated with sepsis using metabolomics. Frontiers in Public Health. 10. 923170–923170. 15 indexed citations
9.
Gu, Shanshan, Ping Yu, Jianan Hu, et al.. (2019). Mitochondria-localizing N-heterocyclic thiosemicarbazone copper complexes with good cytotoxicity and high antimetastatic activity. European Journal of Medicinal Chemistry. 164. 654–664. 55 indexed citations
10.
Deng, Jungang, Yani Liu, Guidong Huang, et al.. (2018). Mixed-ligand Cu(II) hydrazone complexes designed to enhance anticancer activity. European Journal of Medicinal Chemistry. 156. 368–380. 85 indexed citations
11.
Gou, Yi, Dandan Miao, Min Zhou, et al.. (2018). Bio-Inspired Protein-Based Nanoformulations for Cancer Theranostics. Frontiers in Pharmacology. 9. 421–421. 75 indexed citations
12.
Zhang, Yao, Zhenlei Zhang, Yi Gou, et al.. (2017). Design an anticancer copper(II) pro-drug based on the flexible IIA subdomain of human serum albumin. Journal of Inorganic Biochemistry. 172. 1–8. 14 indexed citations
13.
Gou, Yi, Jinlong Li, Bo‐Yi Fan, et al.. (2017). Structure and biological properties of mixed-ligand Cu(II) Schiff base complexes as potential anticancer agents. European Journal of Medicinal Chemistry. 134. 207–217. 104 indexed citations
14.
Deng, Jungang, Yi Gou, Wei Chen, Xiang Fu, & Hang Deng. (2016). The Cu/ligand stoichiometry effect on the coordination behavior of aroyl hydrazone with copper(II): Structure, anticancer activity and anticancer mechanism. Bioorganic & Medicinal Chemistry. 24(10). 2190–2198. 41 indexed citations
15.
Zhang, Zhenlei, Yi Gou, Jun Wang, et al.. (2016). Four copper(II) compounds synthesized by anion regulation: Structure, anticancer function and anticancer mechanism. European Journal of Medicinal Chemistry. 121. 399–409. 30 indexed citations
16.
Gou, Yi, Yao Zhang, Feng Yang, & Hong Liang. (2015). Evaluation of Interactions Between Platinum-/Ruthenium-Based Anticancer Agents and Human Serum Albumin: Development of HSA Carrier for Metal-Based Drugs. Current Pharmaceutical Design. 21(14). 1848–1861. 13 indexed citations
17.
Gou, Yi, Zhan Zhang, Jinxu Qi, et al.. (2015). Folate-functionalized human serum albumin carrier for anticancer copper(II) complexes derived from natural plumbagin. Journal of Inorganic Biochemistry. 153. 13–22. 26 indexed citations
18.
Li, Mei, et al.. (2014). DNA binding, cytotoxicity and apoptosis induction activity of a mixed-ligand copper(II) complex with taurine Schiff base and imidazole. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 128. 686–693. 20 indexed citations
19.
Gou, Yi, Yao Zhang, Jinxu Qi, et al.. (2014). Enhancing the copper(II) complexes cytotoxicity to cancer cells through bound to human serum albumin. Journal of Inorganic Biochemistry. 144. 47–55. 52 indexed citations
20.
Chen, Hua, Hong Cao, Jian Zhou, et al.. (2013). The biological difference between CD13+CD133+ and CD13¬CD133¬liver cancer cells and its clinical significance. SHILAP Revista de lepidopterología. 38(8). 661–664.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Celine J. Marmion Breakdown of academic impact, for papers by Muhammad Nafees Breakdown of academic impact, for papers by Ahmed M. Mansour Breakdown of academic impact, for papers by Adnan S. Abu‐Surrah Breakdown of academic impact, for papers by Claire S. Allardyce Breakdown of academic impact, for papers by Ke-Bin Huang Breakdown of academic impact, for papers by Ignácio E. León Breakdown of academic impact, for papers by Margot N. Wenzel Breakdown of academic impact, for papers by Jinxu Qi
Rankless by CCL
2026